AI assistant
Sending…
Sopharma AD — Earnings Release 2020
Aug 5, 2020
2543_rns_2020-08-05_1ec6d5c8-b316-4f71-aa6b-a811c057bb84.pdf
Earnings Release
Open in viewerOpens in your device viewer
Current report №73/ 2020 Dated August 5, 2020
NOTIFICATION
"Sopharma" AD (the Company) notifies that for July 2020 the Company recorded a decrease in sales of 52% compared to the same month of 2019, incl. 25% decrease in domestic sales and 66% decrease in export sales.
In the first seven months of 2020 the revenues from sales of production decrease by 6% compared to the same period of 2019, incl. 20% decrease of sales for the domestic market and 2% increase in export sales.
Signatures of individuals authorized to represent the Company:
Ognian Donev
More from Sopharma AD
Transaction in Own Shares
2026
May 21
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 19
Transaction in Own Shares
2026
May 18
Transaction in Own Shares
2026
May 15
Transaction in Own Shares
2026
May 14
Transaction in Own Shares
2026
May 13
Transaction in Own Shares
2026
May 12
Transaction in Own Shares
2026
May 11
Regulatory Filings
2026
May 8